We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+3.49%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$6.26B
AUM Growth
+$473M
Cap. Flow
+$398M
Cap. Flow %
6.35%
Top 10 Hldgs %
23.68%
Holding
293
New
38
Increased
125
Reduced
71
Closed
38

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$53.8M
2
ELV icon
Elevance Health
ELV
+$34.6M
3
AET
Aetna Inc
AET
+$33.5M
4
WBA
Walgreens Boots Alliance
WBA
+$32.4M
5
AME icon
Ametek
AME
+$29.1M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$48.5M
2
MRK icon
Merck
MRK
+$37.3M
3
AMGN icon
Amgen
AMGN
+$35M
4
EW icon
Edwards Lifesciences
EW
+$29.3M
5
BAH icon
Booz Allen Hamilton
BAH
+$26.3M

Sector Composition

Rank Sector Weight
1 Financials 23.24%
2 Technology 21.39%
3 Healthcare 21.13%
4 Communication Services 9.82%
5 Industrials 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
176
Eli Lilly
LLY
$1.07T
$5.52M 0.09%
75,000
– –
ZLTQ
177
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$5.44M 0.09%
+125,000
New +$5.04M
ATHN
178
DELISTED
Athenahealth, Inc.
ATHN
$5.38M 0.09%
51,187
-3,147
-6% -$338K
CASH icon
179
Pathward Financial
CASH
$1.85B
$5.26M 0.08%
153,483
+16,857
+12% +$471K
NATI
180
DELISTED
National Instruments Corp
NATI
$5.26M 0.08%
+170,543
New +$4.97M
DFS
181
DELISTED
Discover Financial Services
DFS
$5.23M 0.08%
72,500
-20,000
-22% -$1.27M
INST
182
DELISTED
Instructure, Inc.
INST
$5.13M 0.08%
+261,555
New +$5.61M
UBS icon
183
UBS Group
UBS
$173B
$5.07M 0.08%
303,500
-41,500
-12% -$625K
CRIS icon
184
Curis
CRIS
$10.1M
$4.68M 0.07%
+760
New +$4.57M
TSRO
185
DELISTED
TESARO, Inc.
TSRO
$4.57M 0.07%
34,000
-142,618
-81% -$18M
RPD icon
186
Rapid7
RPD
$642M
$4.54M 0.07%
373,554
+48,950
+15% +$663K
MB
187
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
$4.51M 0.07%
212,449
+41,654
+24% +$842K
ZD icon
188
Ziff Davis
ZD
$1.93B
$4.38M 0.07%
61,533
-19,857
-24% -$1.26M
PPBI
189
DELISTED
Pacific Premier Bancorp
PPBI
$4.29M 0.07%
121,447
-25,605
-17% -$769K
KEY icon
190
KeyCorp
KEY
$24.4B
$4.27M 0.07%
233,560
+206,897
+776% +$3.26M
MBLY
191
DELISTED
Mobileye N.V.
MBLY
$4.24M 0.07%
111,227
-156,085
-58% -$5.87M
MAIN icon
192
Main Street Capital
MAIN
$5.01B
$4.23M 0.07%
115,000
+2,500
+2% +$88.4K
INGN icon
193
Inogen
INGN
$169M
$4.17M 0.07%
+62,155
New +$3.83M
GILD icon
194
Gilead Sciences
GILD
$162B
$4.15M 0.07%
58,000
-10,000
-15% -$743K
NSTG
195
DELISTED
NanoString Technologies, Inc.
NSTG
$4.13M 0.07%
185,000
+104,000
+128% +$2.23M
SUPN icon
196
Supernus Pharmaceuticals
SUPN
$2.75B
$3.91M 0.06%
155,000
+77,500
+100% +$1.73M
PYPL icon
197
PayPal
PYPL
$49.2B
$3.87M 0.06%
98,037
-69,238
-41% -$2.78M
CNC icon
198
Centene
CNC
$31.2B
$3.79M 0.06%
134,000
-539,000
-80% -$15.9M
ICPT
199
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$3.64M 0.06%
33,500
+10,500
+46% +$1.25M
EWBC icon
200
East-West Bancorp
EWBC
$18.2B
$3.56M 0.06%
70,000
– –
6 7
8
9 10

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q4 2016 Portfolio in Review

As of Q4 2016, Polar Capital held 293 positions worth $6.26B, up 8.2% from $5.79B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Polar Capital deployed $398M of net new capital in Q4 2016, opening 38 new positions and adding to 125 existing holdings. Its largest new stake was Aetna Inc: 279,500 shares worth $34.7M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $48.5M trimmed.

  • Polar Capital's largest Q4 2016 buy was Aetna Inc: 279,500 shares worth $34.7M.
  • Polar Capital added most to Alexion Pharmaceuticals in Q4 2016, an estimated $53.8M increase.
  • Polar Capital's biggest Q4 2016 reduction was Johnson & Johnson, cutting an estimated $48.5M.
  • Polar Capital fully exited Edwards Lifesciences in Q4 2016, selling an estimated $29.3M.
  • Polar Capital's ten largest holdings make up 24% of its $6.26B portfolio in Q4 2016.
  • Polar Capital opened 38 new positions and closed 38 in Q4 2016.
  • Polar Capital's portfolio value rose 8.2% quarter-over-quarter to $6.26B.

Based on Polar Capital's 13F filing for Q4 2016, filed 14 Feb 2017.